In fact, the clinical usefulness of p21cip1/waf1 as a prognostic factor has been reported repeatedly for other tumors [33], and our data suggested possible use of p21cip1/waf1 as a prognostic factor in EBV+ HL. This evidence concerns the gene CDKN1A and Hodgkins lymphoma.